T80.61 Other serum reaction due to administration of blood and blood products

Name of the Condition

• Other serum reaction due to administration of blood and blood products.

Summary

This condition describes adverse reactions to serum or blood products that are not classified under more specific categories. These reactions can involve immune-mediated responses or other systemic effects following the administration of blood or blood-derived products.

Causes

Reactions may result from immune responses to foreign proteins in blood products, contamination, or interactions with patient-specific factors. They can also arise from improper handling, storage, or administration of the products.

Risk Factors

• Prior history of serum or blood product reactions
• Underlying immune disorders (e.g., allergies, autoimmune conditions)
• Use of multiple blood products or repeated transfusions
• Patient age (e.g., infants or elderly)
• Pre-existing comorbidities (e.g., kidney disease, infections)

Symptoms

• Fever, chills, or rigors
• Skin reactions (rash, itching, hives)
• Respiratory distress (wheezing, shortness of breath)
• Hypotension or tachycardia
• Nausea, vomiting, or headache
• Flushing or swelling at the infusion site

Diagnosis

Diagnosis involves evaluating clinical presentation, reviewing the blood product administration history, and conducting tests such as blood work or cultures to identify the underlying cause. Documentation of the reaction and product details is critical.

Treatment Options

Treatment focuses on managing symptoms and addressing the underlying reaction. This may include discontinuing the offending product, administering antihistamines or corticosteroids, and providing supportive care (e.g., oxygen, fluids).

Prognosis and Follow-Up

Most reactions are mild and resolve with treatment. Severe reactions may require intensive monitoring. Follow-up ensures resolution of symptoms and assesses for delayed complications.

Complications

• Anaphylaxis (severe allergic reaction)
• Acute kidney injury
• Transfusion-related acute lung injury (TRALI)
• Sepsis (if contaminated products were used)

Lifestyle & Prevention

• Use leukoreduced or washed blood products when appropriate
• Screen donors and products for contaminants
• Monitor patients closely during and after administration
• Document patient history of reactions for future care

When to Seek Professional Help

Seek immediate medical attention if symptoms like difficulty breathing, severe rash, or hypotension occur after blood product administration.

Tips for Medical Coders

Document the specific blood product administered, the timing of the reaction, and clinical findings. Ensure the reaction is not better classified under a more specific code (e.g., allergic reaction). Include details on management and resolution for accurate coding.